Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Dysregulated bile transporters and impaired tight junctions during chronic liver injury in mice.

Pradhan-Sundd T, Vats R, Russell JM, Singh S, Michael AA, Molina L, Kakar S, Cornuet P, Poddar M, Watkins SC, Nejak-Bowen KN, Monga SP, Sundd P.

Gastroenterology. 2018 Jun 28. pii: S0016-5085(18)34690-0. doi: 10.1053/j.gastro.2018.06.048. [Epub ahead of print]

PMID:
29964040
2.

3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression.

Lewis PL, Green RM, Shah RN.

Acta Biomater. 2018 Mar 15;69:63-70. doi: 10.1016/j.actbio.2017.12.042. Epub 2018 Jan 6.

PMID:
29317370
3.

Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.

Pellat A, Vaquero J, Fouassier L.

Hepatology. 2017 Jul 3. doi: 10.1002/hep.29350. [Epub ahead of print] Review.

PMID:
28671339
4.

A Predictive 3D Multi-Scale Model of Biliary Fluid Dynamics in the Liver Lobule.

Meyer K, Ostrenko O, Bourantas G, Morales-Navarrete H, Porat-Shliom N, Segovia-Miranda F, Nonaka H, Ghaemi A, Verbavatz JM, Brusch L, Sbalzarini I, Kalaidzidis Y, Weigert R, Zerial M.

Cell Syst. 2017 Mar 22;4(3):277-290.e9. doi: 10.1016/j.cels.2017.02.008. Epub 2017 Mar 18.

5.

Liver: PET for bile transport kinetics.

Dickson I.

Nat Rev Gastroenterol Hepatol. 2017 May;14(5):260-261. doi: 10.1038/nrgastro.2017.36. Epub 2017 Mar 15. No abstract available.

PMID:
28293029
6.

Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.

Lepist EI, Gillies H, Smith W, Hao J, Hubert C, St Claire RL 3rd, Brouwer KR, Ray AS.

PLoS One. 2014 Jan 30;9(1):e87548. doi: 10.1371/journal.pone.0087548. eCollection 2014.

7.

Increased hepatic blood flow during enteral immune-enhancing diet gavage requires intact enterohepatic bile cycling.

Nagengast AK, Hurt RT, Downard CD, Smith JW, Garrison RN, Matheson PJ.

Nutrition. 2014 Mar;30(3):313-8. doi: 10.1016/j.nut.2013.08.006. Epub 2013 Dec 17.

PMID:
24355437
8.

Drug-induced cholestasis.

Bhamidimarri KR, Schiff E.

Clin Liver Dis. 2013 Nov;17(4):519-31, vii. doi: 10.1016/j.cld.2013.07.015. Review.

PMID:
24099015
9.

Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats.

Tarantola E, Bertone V, Milanesi G, Capelli E, Ferrigno A, Neri D, Vairetti M, Barni S, Freitas I.

Eur J Histochem. 2012 Oct 8;56(4):e41. doi: 10.4081/ejh.2012.e41.

10.

An update on genetic analysis of cholestatic liver diseases: digging deeper.

Müllenbach R, Lammert F.

Dig Dis. 2011;29(1):72-7. doi: 10.1159/000324137. Epub 2011 Jun 17. Review.

11.

[Forensic-medical evaluation of toxic hepatitis associated with surrogate alcohol poisoning].

Solodun IuV, Klevno VA, Leliukh TD, Maslauskaĭte LS, Iaverbaum AP, Ermolaeva NB, Zobnin IuV, Provado IP, Kuchina EV, Bogomolova IN.

Sud Med Ekspert. 2008 Jul-Aug;51(4):23-8. Russian.

PMID:
18756761
12.

[ABC transporter proteins in multidrug resistance of microorganisms].

Balková K, Gbelská Y.

Epidemiol Mikrobiol Imunol. 2007 Aug;56(3):129-39. Review. Slovak.

PMID:
17900061
13.

The genetics of ATP-binding cassette transporters.

Dean M.

Methods Enzymol. 2005;400:409-29. Review.

PMID:
16399363
14.

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study.

Fletcher N, Wahlström D, Lundberg R, Nilsson CB, Nilsson KC, Stockling K, Hellmold H, Håkansson H.

Toxicol Appl Pharmacol. 2005 Aug 22;207(1):1-24.

PMID:
16054898
15.

Progressive familial intrahepatic cholestasis: genetic disorders of biliary transporters.

Harris MJ, Le Couteur DG, Arias IM.

J Gastroenterol Hepatol. 2005 Jun;20(6):807-17. Review.

PMID:
15946126
16.
17.
18.

The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease.

Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, Ramm GA.

Am J Pathol. 2002 May;160(5):1705-15.

19.

Therapies on the horizon for cholesterol reduction.

Brown WV.

Clin Cardiol. 2001 Aug;24(8 Suppl):III24-7. Review.

20.

The human ATP-binding cassette (ABC) transporter superfamily.

Dean M, Hamon Y, Chimini G.

J Lipid Res. 2001 Jul;42(7):1007-17. Review.

Supplemental Content

Loading ...
Support Center